Koyfin Home > Directory > Health Care > Arbutus Biopharma Cp > EBITDA / Interest Expenses

Arbutus Biopharma Cp EBITDA / Interest Expenses Chart (ABUS)

Arbutus Biopharma Cp annual/quarterly EBITDA / Interest Expenses from 2006 to 2006. EBITDA / Interest is the interest coverage ratio and measures the ability of a company to service its debt.
  • Arbutus Biopharma Cp EBITDA / Interest Expenses for the quarter ending June 06, 2006 was $4m
  • Arbutus Biopharma Cp EBITDA / Interest Expenses for the last 12 months ending March 03, 2007 was $11m
Other Ratios Metrics:
  • Arbutus Biopharma Cp Total Debt / Capital for the quarter ending December 12, 2017 was $6m a 3.27% increase of 0m year over year
  • Arbutus Biopharma Cp Other Liabilities for the quarter ending December 12, 2018 was $17m a -61.02% decrease of -10m year over year
  • Arbutus Biopharma Cp Total Debt / Equity for the quarter ending December 12, 2017 was $7m a 3.48% increase of 0m year over year
View Chart On Koyfin

Quarterly ABUS EBITDA / Interest Expenses Data

06/2006$4m

Annual ABUS EBITDA / Interest Expenses Data

2006$3m